Physician profile
Brian J Keyes
NPI 1417078890
$10,947.67
in general payments reported to CMS, 2019-2025
12 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,412 · 2020: $1,050 · 2021: $749 · 2022: $350 · 2023: $3,009 · 2024: $2,622 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,113 · Food and Beverage: $2,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,113.09 |
| Food and Beverage | $2,273.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,645.77 | 2019-2025 | Mako, Accolade, Insignia |
| Zimmer Biomet Holdings, INC. | $2,074.14 | 2019-2025 | |
| Depuy Synthes Products, INC. | $541.00 | 2023 | Velys |
| Depuy Synthes Sales INC. | $325.18 | 2023-2025 | Tfn-Advance, Actis, Velys |
| Smith+Nephew, INC. | $87.36 | 2025 | Real Intelligence |
| Medacta USA, INC. | $82.76 | 2023 | Gmk Sphere |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Medtronic, INC. | $47.63 | 2025 | Mazor X System |
| Solventum Corporation | $22.14 | 2025 | Prevena |
| Pacira Pharmaceuticals Incorporated | $21.43 | 2023 | Exparel, Iovera |
| Davol INC. | $19.57 | 2023 | Arista Ah Flexitip |
| Enduromed, LLC | $18.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.